Expert Review of Neurotherapeutics
Displaying 1 - 5 of 5
Delgardo, M., Rabin, G., Tudor, T., Tang, A. J., Reeves, G., & Connolly, E. S. (2023). Monitoring risk and preventing ischemic stroke in the very old. Expert Review of Neurotherapeutics, 23(9), 791–801. https://doi.org/10.1080/14737175.2023.2244674
Publication Date
Columbia Affiliation
View
Fulop, T., Ramassamy, C., Lévesque, S., Frost, E. H., Laurent, B., Lacombe, G., Khalil, A., Larbi, A., Hirokawa, K., Desroches, M., Rodrigues, S., Bourgade, K., Cohen, A. A., & Witkowski, J. M. (2023). Viruses - a major cause of amyloid deposition in the brain. Expert Review of Neurotherapeutics, 23(9), 775–790. https://doi.org/10.1080/14737175.2023.2244162
Publication Date
Columbia Affiliation
View
Mann, J. J., & Rizk, M. M. (2023). Rethinking the medication management of major depression. Expert Review of Neurotherapeutics, 23(4), 331–363. https://doi.org/10.1080/14737175.2023.2190886
Publication Date
Columbia Affiliation
View
Yang, D., & Elkind, M. S. V. (2023). Current perspectives on the clinical management of cryptogenic stroke. Expert Review of Neurotherapeutics, 23(3), 213–226. https://doi.org/10.1080/14737175.2023.2192403
Publication Date
Columbia Affiliation
View
Brewster, K. K., Deal, J. A., Lin, F. R., & Rutherford, B. R. (2022). Considering hearing loss as a modifiable risk factor for dementia. Expert Review of Neurotherapeutics, 22(9), 805–813. https://doi.org/10.1080/14737175.2022.2128769
Publication Date
Columbia Affiliation